- Home
- CDTX vs IIPR Comparison
CDTX vs IIPR Comparison
Compare CDTX & IIPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDTX
- IIPR
- Stock Information
- Founded
- CDTX 2012
- IIPR 2016
- Country
- CDTX United States
- IIPR United States
- Employees
- CDTX N/A
- IIPR N/A
- Industry
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- IIPR Real Estate
- Sector
- CDTX Health Care
- IIPR Finance
- Exchange
- CDTX Nasdaq
- IIPR Nasdaq
- Market Cap
- CDTX 1.4B
- IIPR 1.5B
- IPO Year
- CDTX 2015
- IIPR 2016
- Fundamental
- Price
- CDTX $66.37
- IIPR $54.92
- Analyst Decision
- CDTX Strong Buy
- IIPR Hold
- Analyst Count
- CDTX 11
- IIPR 8
- Target Price
- CDTX $57.00
- IIPR $88.75
- AVG Volume (30 Days)
- CDTX 427.5K
- IIPR 382.9K
- Earning Date
- CDTX 08-07-2025
- IIPR 08-06-2025
- Dividend Yield
- CDTX N/A
- IIPR 13.84%
- EPS Growth
- CDTX N/A
- IIPR N/A
- EPS
- CDTX N/A
- IIPR 4.63
- Revenue
- CDTX N/A
- IIPR $287,883,000.00
- Revenue This Year
- CDTX N/A
- IIPR N/A
- Revenue Next Year
- CDTX N/A
- IIPR $0.94
- P/E Ratio
- CDTX N/A
- IIPR $11.85
- Revenue Growth
- CDTX N/A
- IIPR N/A
- 52 Week Low
- CDTX $10.14
- IIPR $45.44
- 52 Week High
- CDTX $69.36
- IIPR $138.35
- Technical
- Relative Strength Index (RSI)
- CDTX 65.51
- IIPR 57.15
- Support Level
- CDTX $59.80
- IIPR $51.91
- Resistance Level
- CDTX $69.36
- IIPR $53.50
- Average True Range (ATR)
- CDTX 3.83
- IIPR 1.92
- MACD
- CDTX -0.38
- IIPR 0.49
- Stochastic Oscillator
- CDTX 76.70
- IIPR 94.20
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
About IIPR Innovative Industrial Properties Inc.
Innovative Industrial Properties Inc is a real estate investment trust engaged in the acquisition, ownership, and management of specialized industrial properties leased to state-licensed operators for their regulated medical-use cannabis facilities. It conducts its business through a traditional umbrella partnership real estate investment trust, or UPREIT structure, in which properties are owned by Operating Partnership, directly or through subsidiaries. Its property portfolio is spread across the United States.